Exposure to pharmaceuticals in compounding environments can lead to a number of health risks for pharmaceutical employees and patients. These health risks can range from contact with hazardous waste materials, harmful particulates during pressure changes or even transmissible disease.
In recent years, container closure integrity (CCI) testing has steadily moved up the pharmaceutical manufacturing agenda. Latest research has shown that not only ampoules are prone to CCI defects. Other primary packaging types such as vials, cartridges and syringes equally require thorough testing, especially when filled with lyophilized products. Consequently, the United States Pharmacopeia (USP) has been revising its General Chapter 1207, calling for more quantitative, validated CCI test methods. A significant shift is expected towards non-destructive technologies.
A Nelson & Co Ltd. who manufacture natural healthcare remedies, have experienced an increase in production demands, therefore a solution was required for an automatic process for precise weighing and the collating of production data.
Quality control of Clairol Nice 'n Easy hair colorant kits, packed in cartons at Procter & Gamble's Seaton Delaval site near Newcastle, has been automated with a new checkweigher, custom built by OCS to meet P&G's specific needs.
At the end of a production line the question occurs again and again: "Is everything in the package that belongs there?" The answer is given by the modular construction of the TQCC.
Manufacturers who produce very small objects such as tablets need a dependable and precise quality instrument.
It is important that medications be taken as prescribed by a doctor. Otherwise, there is a possibility that undesirable side effects may occur.